M. Merlano

Etoposideversus etoposide plus high-dose cisplatin in the management of advanced non-small cell lung cancer: Results of a prospective randomized fonicap trial

Riccardo Rosso, Franco Salvati, Andrea Ardizzoni et al. · Cancer · 1990 · 53 citations

Medicine, Oncology, Pharmacology +10

Phase II study of cisplatin, gemcitabine and 5-fluorouracil in advanced pancreatic cancer

Anna Novarino, Isabella Chiappino, Gianfilippo Bertelli et al. · Annals of Oncology · 2004 · 29 citations

Medicine, Oncology, Pharmacology +14

The triplet combination of irinotecan, oxaliplatin and 5FU/LV (FOLFOXIRI) vs the doublet of irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal cancer (MCRC): Results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.)

Alfredo Falcone, Gianluca Masi, I. Brunetti et al. · Journal of Clinical Oncology · 2006 · 25 citations

Medicine, Oncology, Pharmacology +16

Chemotherapy for relapsed head and neck cancer: paclitaxel, cisplatin, and 5-fluorouracil in chemotherapy-naive patients. A dose-finding study.

Marco Benasso, Gianmauro Numico, R. Rosso et al. · PubMed · 1997 · 15 citations

Medicine, Oncology, Pharmacotherapy +9

Phase I-II trial with cisplatin and 5-FU in recurrent head and neck cancer: an effective outpatient schedule.

M. Merlano, Rita Tatarek, A. Grimaldi et al. · PubMed · 1985 · 13 citations

Medicine, Oncology, Pharmacotherapy +14